Autism – The neural basis of sensory hypersensitivity

A new study may explain why people with autism are often highly sensitive to light and noise.Anne Trafton | MIT News OfficePublication Date:

MIT neuroscientists have discovered a brain circuit that appears to contribute to the sensory hypersensitivity often seen in people with autism spectrum disorders.

MIT neuroscientists have discovered a brain circuit that appears to contribute to the sensory hypersensitivity often seen in people with autism spectrum disorders. Credits: Image: Jose-Luis Olivares, MIT

Many people with autism spectrum disorders are highly sensitive to light, noise, and other sensory input. A new study in mice reveals a neural circuit that appears to underlie this hypersensitivity, offering a possible strategy for developing new treatments.

MIT and Brown University neuroscientists found that mice lacking a protein called Shank3, which has been previously linked with autism, were more sensitive to a touch on their whiskers than genetically normal mice. These Shank3-deficient mice also had overactive excitatory neurons in a region of the brain called the somatosensory cortex, which the researchers believe accounts for their over-reactivity.

There are currently no treatments for sensory hypersensitivity, but the researchers believe that uncovering the cellular basis of this sensitivity may help scientists to develop potential treatments.

“We hope our studies can point us to the right direction for the next generation of treatment development,” says Guoping Feng, the James W. and Patricia Poitras Professor of Neuroscience at MIT and a member of MIT’s McGovern Institute for Brain Research.

Feng and Christopher Moore, a professor of neuroscience at Brown University, are the senior authors of the paper, which appears today in Nature Neuroscience. McGovern Institute research scientist Qian Chen and Brown postdoc Christopher Deister are the lead authors of the study.

Too much excitation

The Shank3 protein is important for the function of synapses — connections that allow neurons to communicate with each other. Feng has previously shown that mice lacking the Shank3 gene display many traits associated with autism, including avoidance of social interaction, and compulsive, repetitive behavior.

In the new study, Feng and his colleagues set out to study whether these mice also show sensory hypersensitivity. For mice, one of the most important sources of sensory input is the whiskers, which help them to navigate and to maintain their balance, among other functions.

The researchers developed a way to measure the mice’s sensitivity to slight deflections of their whiskers, and then trained the mutant Shank3 mice and normal (“wild-type”) mice to display behaviors that signaled when they felt a touch to their whiskers. They found that mice that were missing Shank3 accurately reported very slight deflections that were not noticed by the normal mice.

“They are very sensitive to weak sensory input, which barely can be detected by wild-type mice,” Feng says. “That is a direct indication that they have sensory over-reactivity.”

Once they had established that the mutant mice experienced sensory hypersensitivity, the researchers set out to analyze the underlying neural activity. To do that, they used an imaging technique that can measure calcium levels, which indicate neural activity, in specific cell types.

They found that when the mice’s whiskers were touched, excitatory neurons in the somatosensory cortex were overactive. This was somewhat surprising because when Shank3 is missing, synaptic activity should drop. That led the researchers to hypothesize that the root of the problem was low levels of Shank3 in the inhibitory neurons that normally turn down the activity of excitatory neurons. Under that hypothesis, diminishing those inhibitory neurons’ activity would allow excitatory neurons to go unchecked, leading to sensory hypersensitivity.

To test this idea, the researchers genetically engineered mice so that they could turn off Shank3 expression exclusively in inhibitory neurons of the somatosensory cortex. As they had suspected, they found that in these mice, excitatory neurons were overactive, even though those neurons had normal levels of Shank3.

“If you only delete Shank3 in the inhibitory neurons in the somatosensory cortex, and the rest of the brain and the body is normal, you see a similar phenomenon where you have hyperactive excitatory neurons and increased sensory sensitivity in these mice,” Feng says.

Reversing hypersensitivity

The results suggest that reestablishing normal levels of neuron activity could reverse this kind of hypersensitivity, Feng says.

“That gives us a cellular target for how in the future we could potentially modulate the inhibitory neuron activity level, which might be beneficial to correct this sensory abnormality,” he says.

Many other studies in mice have linked defects in inhibitory neurons to neurological disorders, including Fragile X syndrome and Rett syndrome, as well as autism.

“Our study is one of several that provide a direct and causative link between inhibitory defects and sensory abnormality, in this model at least,” Feng says. “It provides further evidence to support inhibitory neuron defects as one of the key mechanisms in models of autism spectrum disorders.”

He now plans to study the timing of when these impairments arise during an animal’s development, which could help to guide the development of possible treatments. There are existing drugs that can turn down excitatory neurons, but these drugs have a sedative effect if used throughout the brain, so more targeted treatments could be a better option, Feng says.

“We don’t have a clear target yet, but we have a clear cellular phenomenon to help guide us,” he says. “We are still far away from developing a treatment, but we’re happy that we have identified defects that point in which direction we should go.”

Brain Organoids Mimic Head Size Changes Associated with Type of Autism

Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic interventions

Variations in the 16p11.2 region of the genome are associated with autism spectrum disorder. While people with genetic deletions in this region have larger heads (macrocephaly) and people with genetic duplications have smaller heads (microcephaly), both variation types affect brain development and function.

To study the effects of these variations and search for ways to minimize their impact, University of California San Diego School of Medicine researchers are using brain organoids — tiny, 3D cellular models generated in the lab from people with 16p11.2 variations.

The organoids, described in a paper publishing August 25, 2021 in Molecular Psychiatry , mimicked the differences in brain size seen in people. They also revealed new information about the molecular mechanisms that malfunction when the 16p11.2 region of the genome is disrupted, providing new opportunities for potential therapeutic intervention.

macro v. microcephaly

Variations in the 16p11.2 region of the genome are associated with autism spectrum disorder and changes in head size. Brain organoids grown in the lab with a 16p11.2 deletion demonstrate macrocephaly (larger size, left), while 16p11.2 duplication demonstrates microcephaly (smaller size, right).

“Because our organoids recapitulate the head size of the patients, that tells us this can be a useful model,” said senior author Lilia Iakoucheva, PhD, associate professor of psychiatry at UC San Diego School of Medicine. “And we need better models to study autism spectrum disorder, especially during fetal development.”



Iakoucheva led the study with Alysson Muotri, PhD, professor of pediatrics and cellular and molecular medicine at UC San Diego School of Medicine.

The brain organoids were created using induced pluripotent stem cells derived from people who have 16p11.2 genomic variations — three people with deletions, three with duplications and three non-variant controls. Researchers obtained a skin sample from each person, gave the skin cells a molecular cocktail that converted them to stem cells, then treated the stem cells in a way that coaxed them into becoming brain cells, preserving each patient’s unique genetic background.

The organoids revealed that RhoA — a protein that plays a big part in many basic cellular functions, such as development and movement — is more active in both 16p11.2-deleted and 16p11.2-duplicated organoids than it is in organoids without these variations. Over-active RhoA led to a slowdown in neuronal migration, the process by which brain cells get to where they need to be for normal fetal development and function in adulthood.

When the team inhibited RhoA in the autism-like organoids, neuronal migration was restored to levels seen in the control organoids.

“Our work opens the possibility to therapeutically manipulate the RhoA pathway,” said Muotri, who is also director of the UC San Diego Stem Cell Program and a member of the Sanford Consortium for Regenerative Medicine. “The same pathway may be also damaged in other individuals with autism spectrum disorder who have macrocephaly or microcephaly. Considering this, we can potentially help millions of patients.”

Organoids aren’t perfect reproductions of the brain. They lack connections to other organ systems, such as blood vessels, and so don’t encapsulate full human biology. In addition, therapeutics tested on brain organoids are added directly. They don’t need to get across the blood-brain barrier, specialized blood vessels that keep the brain largely free of microbes and toxins.

The team plans to further test RhoA inhibitors in a mouse model with 16p11.2 variations or over-active RhoA for their ability to reverse defects associated with autism spectrum disorder.

Co-authors include: Jorge Urresti, Pan Zhang, Patricia Moran-Losada, Priscilla D. Negraes, Cleber A. Trujillo, Danny Antaki, Megha Amar, Kevin Chau, Akula Bala Pramod, Leon Tejwani, Sarah Romero, and Jonathan Sebat, all at UC San Diego; Nam-Kyung Yu, Jolene Diedrich, and John R. Yates III, Scripps Research.

Family-centered nutrition influences diet behaviors for children with autism

Children with autism benefit from group-based weight management, according to a new article in the Journal of Nutrition Education and Behavior

Adapting family-centered nutrition programs can positively influence diet behaviors in children with autism, according to a new study in the Journal of Nutrition Education and Behavior, published by Elsevier.

Autism is one of the most common developmental disabilities in children. Because many children with autism battle with obesity, researchers evaluated the adaptation and implementation of an existing, evidence-based nutrition program for children with autism and their parents.

“Historically, children with autism have been excluded from this type of programming often designed for neurotypical kids. We know that children with autism face greater challenges. One of these challenges is that they often have two to five times the rate of obesity than other kids. So, we wanted to help this population that often lacks these specialized resources,” said Brenda Manzanarez, MS, RD, The Diabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, USA.

Children aged 7−12 years with autism and their parents participated in six weekly, 90-minute classes attended by the whole family as part of the Kids N Fitness© program developed at Children’s Hospital Los Angeles. Each class was structured around four core elements: (1) family-centered nutrition education; (2) parent support; (3) physical activity; and (4) goal setting.

Kids N Fitness for All Learning Levels was adapted from a variation of KNF created for children aged 3−7 years and featured training topics including an overview of each class, program activities unique to KNF4ALL, and strategies for working with children with autism spectrum disorder (Credit: Kids N Fitness©).

We had trained staff that delivered the curriculum along with applied behavior analyst therapists who provided support and feedback on how we could improve the curriculum. At the end of the sessions, we found it challenging to keep up the retention of families, with about 26% completing the program. Interestingly, we found that those who did complete the entire program did have 100% attendance,” Manzanarez continued. “The families voiced that they liked the program and seeing changes in their kids like improving their eating habits, being more positive, and engaging in exercise as a form of movement.”

Families reported valuing the opportunity to ask questions and share successful experiences and approaches to increase their child’s healthy food repertoire. On completing participation in the pilot, families reported their children to be more willing to try new foods, proactively added colorful foods to their plate during mealtimes, and expressed greater interest in exercise. In addition, the curriculum seemed to resonate with child participants, as documented by both staff and parents, who noted that children recalled main messages from prior weeks’ lessons.

The increasing prevalence of autism and childhood obesity merits innovative interventions involving the whole family. Family-based community programs that address problematic mealtime behaviors and provide family-centered nutrition education may prove an important adjunct or alternative to more time a resource-intensive one-on-one interventions, such as traditional feeding therapies. As children with autism are often excluded from traditional learning settings, findings from this pilot can contribute to the development of evidence-based practices of community-based nutrition interventions for children with autism and their families.

Signs and Symptoms of Sensory Processing Disorder

Signs and Symptoms of Sensory Processing Disorder by Brain Balance Centers  - YouTube


Sensory Processing Disorder (SPD), also called sensory integration dysfunction, is a neurological difference characterized by either a hypersensitivity (over-responsiveness) or hyposensitivity (under-responsiveness) to one’s surroundings due to the brain’s inability to properly integrate multi-sensory input. While all children may be quirky or particular about their likes and dislikes, children with SPD are so severely affected by their sensory preferences that it interferes with normal, everyday functioning. Children with hypersensitivity to sensory input may exhibit extreme or fearful responses to touch, textures, noise, crowds, lights, and smells, even when these inputs seem benign to others.

Children with hyposensitivity to sensory input may exhibit an under-reaction or high tolerance to pain, may constantly and inappropriately touch or bump into people and objects, be fidgety, and are often characterized as “thrill seekers,” leading to inadvertently putting themselves or others in danger.